KWIK-STIK, Candida parapsilosis derived from ATCC 22019, REF 0726P. Packaged 2 units per pack. ...
FDA Device Recall #Z-0543-2022 — Class III — February 24, 2021
Recall Summary
| Recall Number | Z-0543-2022 |
| Classification | Class III — Low risk |
| Date Initiated | February 24, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Microbiologics Inc |
| Location | Saint Cloud, MN |
| Product Type | Devices |
| Quantity | 65 packs (130 units) |
Product Description
KWIK-STIK, Candida parapsilosis derived from ATCC 22019, REF 0726P. Packaged 2 units per pack. IVD controls.
Reason for Recall
Potential that products packaged for lot 726-57-10 were packaged in pouches labeled as 323-108-7.
Distribution Pattern
Worldwide distribution - US distribution in the states of GA, MS, MT, NC, NM, NV, TN, TX, WA, WI and the countries of Brazil, Canada, China, Colombia, Dominican Republic, France, India, Ireland, Japan, Mexico, Oman, Philippines, Romania, South Africa, Turkey, United Arab Emirates.
Lot / Code Information
Catalog Number: 0726P, Lot Number: 726-57-10, UDI: 20845357017486
Other Recalls from Microbiologics Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0986-2026 | Class II | LYFO DISK, Campylobacter jejuni subsp. jejuni d... | Dec 2, 2025 |
| Z-0984-2026 | Class II | KWIK-STIK 2-Pack, Campylobacter jejuni subsp. j... | Dec 2, 2025 |
| Z-0985-2026 | Class II | KWIK-STIK 6-Pack, Campylobacter jejuni subsp. j... | Dec 2, 2025 |
| Z-0876-2026 | Class II | KWIK-STIK, Quality control kit for culture medi... | Nov 13, 2025 |
| Z-2194-2025 | Class II | LYFO-DISK, M. Canis Derived from ATCC 36299, pa... | Jun 27, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.